ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A11System DisorderSTUDENT NAME _____________________________________DISORDER/DISEASE PROCESS __________________________________________________________ REVIEW MODULE CHAPTER ___________ACTIVE LEARNING TEMPLATE: ASSESSMENTSAFETY CONSIDERATIONS
PATIENT-CENTERED CAREAlterations in Health (Diagnosis)Pathophysiology Related to Client ProblemHealth Promotion and Disease PreventionRisk FactorsExpected FindingsLaboratory TestsDiagnostic Procedures
Complications
Therapeutic ProceduresInterprofessional CareNursing CareClient EducationMedicationsRisk of infection due to altered immune protectionProgressively depletes CD4 T lymphocytes and ends with symptomatic acquired immunodeficiency syndrome (AIDS) -Get tests of HIV or STD’s along with your partner(s).
-Do not share injection equipment.
-Use condoms during sexual intercourse. -Talk to your PCP about pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-Proper sterilization and disinfection procedures must be followed to prevent infection risk. -Health care professionals should practice hand-hygiene before and after caring for a patient to prevent harm to the immunodeficient patient and prevent spread of HIV to other patients. -All health care workers should use barrier precautions to prevent skin and mucous membrane exposure if in contact with blood or other body fluids. -Visitors should be educated on safety precautions to avoid transmission of the virus. -Unprotected sex (sex without condoms)
-Have multiple sex partners -Sharing syringes and/or other injection equipment
-Babies born to HIV-positive mothers who did not receive HIV therapy during pregnancy. -Having open wounds or being exposed to bodily fluids from an HIV-positive person. -Flu like signs or symptoms such as fever -Frequent vaginal yeast infections -Mouth sores (yeast) -Skin rashes (seborrheic, dermatitis, and psoriasis) -Swollen lymph nodes -Weight loss -Anitgen/Antibody tests: tests for HIV antigens and antibodies. -Saliva Tests: positive results are confirmed with a blood test. -Viral Load Test: measures the amount of HIV in the blood.-Enzyme-linked immunosorbent assay (ELISA) Test: used to detect HIV antibodies and confirm the diagnosis -Western Blot: used to confirm a positive ELISA. -Monitor the progression of symptoms, disease progression, and immune function of the patient. -Monitor antiretroviral therapy and determine effectiveness of the medications -Detect and document any development of opportunistic diseases. -Monitor patients liver function throughout treatment. -Offer supper groups to patients especially if their thought process reflects depression. -Antivirals Acyclovir -Antiretrovirals: Fusion/Entry Inhibitors Enfuviride -Antiretrovirals: CCR5 antagonists Maraviroc -Antiretrovirals: NRTI’s Zidovudine -Antiretrovirals: NNRTI’s Delavirdine -Antiretrovirals: Protease Inhibitors
Ritonavir -Antiretrovirals: Integrase Inhibitors (INSTI’s) Raltegravir -Antiretroviral therapy: following a daily regimen of medications (ususally 3) that will stop the virus from replication -Support Groups: attending support group meeting to prevent risk of harm to mental health. -Advise the patient not to donate blood, organs, or semen. -Advise patients not to breastfeed. -Educate patient on the use of condoms. -Educate patient on signs and symptoms of liver failure -Educate patient on when they should be returning to the hospitals-Primary Care Provider -Infectious Disease Specialist -Nurses -Pharmacists -Mental Health Provider -Case manager -Risk of developing opportunistic infections. -HIV-associated retinopathy. -Impaired lipid and glucose metabolism. -Lipodystrophy -Myopathy
-Non-alcoholic fatty liver disease -Anemia -Hepatotoxicity -DeathHuman Immunodeficiency Virus (HIV)48
PATIENT-CENTERED CAREAlterations in Health (Diagnosis)Pathophysiology Related to Client ProblemHealth Promotion and Disease PreventionRisk FactorsExpected FindingsLaboratory TestsDiagnostic Procedures
Complications
Therapeutic ProceduresInterprofessional CareNursing CareClient EducationMedicationsRisk of infection due to altered immune protectionProgressively depletes CD4 T lymphocytes and ends with symptomatic acquired immunodeficiency syndrome (AIDS) -Get tests of HIV or STD’s along with your partner(s).
-Do not share injection equipment.
-Use condoms during sexual intercourse. -Talk to your PCP about pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-Proper sterilization and disinfection procedures must be followed to prevent infection risk. -Health care professionals should practice hand-hygiene before and after caring for a patient to prevent harm to the immunodeficient patient and prevent spread of HIV to other patients. -All health care workers should use barrier precautions to prevent skin and mucous membrane exposure if in contact with blood or other body fluids. -Visitors should be educated on safety precautions to avoid transmission of the virus. -Unprotected sex (sex without condoms)
-Have multiple sex partners -Sharing syringes and/or other injection equipment
-Babies born to HIV-positive mothers who did not receive HIV therapy during pregnancy. -Having open wounds or being exposed to bodily fluids from an HIV-positive person. -Flu like signs or symptoms such as fever -Frequent vaginal yeast infections -Mouth sores (yeast) -Skin rashes (seborrheic, dermatitis, and psoriasis) -Swollen lymph nodes -Weight loss -Anitgen/Antibody tests: tests for HIV antigens and antibodies. -Saliva Tests: positive results are confirmed with a blood test. -Viral Load Test: measures the amount of HIV in the blood.-Enzyme-linked immunosorbent assay (ELISA) Test: used to detect HIV antibodies and confirm the diagnosis -Western Blot: used to confirm a positive ELISA. -Monitor the progression of symptoms, disease progression, and immune function of the patient. -Monitor antiretroviral therapy and determine effectiveness of the medications -Detect and document any development of opportunistic diseases. -Monitor patients liver function throughout treatment. -Offer supper groups to patients especially if their thought process reflects depression. -Antivirals Acyclovir -Antiretrovirals: Fusion/Entry Inhibitors Enfuviride -Antiretrovirals: CCR5 antagonists Maraviroc -Antiretrovirals: NRTI’s Zidovudine -Antiretrovirals: NNRTI’s Delavirdine -Antiretrovirals: Protease Inhibitors
Ritonavir -Antiretrovirals: Integrase Inhibitors (INSTI’s) Raltegravir -Antiretroviral therapy: following a daily regimen of medications (ususally 3) that will stop the virus from replication -Support Groups: attending support group meeting to prevent risk of harm to mental health. -Advise the patient not to donate blood, organs, or semen. -Advise patients not to breastfeed. -Educate patient on the use of condoms. -Educate patient on signs and symptoms of liver failure -Educate patient on when they should be returning to the hospitals-Primary Care Provider -Infectious Disease Specialist -Nurses -Pharmacists -Mental Health Provider -Case manager -Risk of developing opportunistic infections. -HIV-associated retinopathy. -Impaired lipid and glucose metabolism. -Lipodystrophy -Myopathy
-Non-alcoholic fatty liver disease -Anemia -Hepatotoxicity -DeathHuman Immunodeficiency Virus (HIV)48
